| [February 11, 2010] |
 |
Research and Markets: Company Financials Report: Schering-Plough Corporation Signed a $41.1 Billion Merger Agreement with its Big Pharma Rival Merck & Co. in March 2009
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/8777c0/company_financials) has announced the addition of the "Company Financials: Schering-Plough Corporation" company profile to their offering.
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
Provides key ratios
Includes information on revenue distribution by business segments and geographies
Highlights of this title
Schering-Plough, which signed a $41.1 billion merger agreement with its Big Pharma rival Merck & Co. in March 2009, is engaged in the discovery, development and manufacture of human prescription, animal health and consumer health care products. The company is headquartered in Kenilworth, New Jersey and employs 51,000 people.
Key reasons to purchase this title
Access important financial information and analysis on the company in a single datapack
Understand the financial evolution of the company over the last five years
Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
For more information visit http://www.researchandmarkets.com/research/8777c0/company_financials
Source: Datamonitor
[ InfoTech Spotlight's Homepage ]
|